Development of resveratrol-conjugated gold nanoparticles: interrelationship of increased resveratrol corona on anti-tumor efficacy against breast, pancreatic and prostate cancers
Received 7 February 2019
Accepted for publication 17 April 2019
Published 18 June 2019 Volume 2019:14 Pages 4413—4428
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Prof. Dr. Thomas J. Webster
Velaphi C Thipe,1,2 Kiandohkt Panjtan Amiri,3 Pierce Bloebaum,2,4 Alice Raphael Karikachery,2,5 Menka Khoobchandani,2,5 Kavita K Katti,2,5 Silvia S Jurisson,1,6 Kattesh V Katti2,4–7
1Department of Chemistry, University of Missouri, Columbia, MO 65201, USA; 2Institute of Green Nanotechnology, University of Missouri, Columbia, MO 65211, USA; 3Department of Physics, Washington University, St. Louis, MO 63130, USA; 4Department of Physics and Astronomy; 5Department of Radiology; 6University of Missouri Research Reactor, University of Missouri, Columbia, MO 65211, USA; 7Department of Medical Pharmacology and Physiology, University of Missouri, Columbia, MO 65211, USA
Background: As part of our continuing quest to enhance the efficacy of bioactive phytochemicals in cancer therapy, we report an innovative green nanotechnology approach toward the use of resveratrol for the production of biocompatible resveratrol-conjugated gold nanoparticles (Res-AuNPs). Our overarching aim is to exploit the inherent pro-apoptotic properties of gold nanoparticles (AuNPs) through synergistic anti-tumor characteristics of resveratrol, with the aim of developing a new class of green nanotechnology-based phytochemical-embedded AuNPs for applications in oncology.
Method: Resveratrol was used to reduce Au3+, to Au0, for the synthesis of Res-AuNPs at room temperature and gum arabic (GA) was used to further encapsulate the nanoparticulate surface to increase the overall stability of the AuNPs. This comprehensive study involves the synthesis, full characterization and in vitro stability of Res-AuNPs in various biological media for their ultimate applications as anti-cancer agents against human breast (MDAMB-231), pancreatic (PANC-1) and prostate (PC-3) cancers.
Results: This strategy to systematically increase the corona of resveratrol on AuNPs, in order to gain insights into the interrelationship of the phytochemical corona on the overall anti-tumor activities of Res-AuNPs, proved successful. The increased resveratrol corona on Res-AuNPs showed superior anti-cancer effects, attributed to an optimal cellular uptake after 24-hour incubation, while GA provided a protein matrix support for enhanced trans-resveratrol loading onto the surface of the AuNPs.
Conclusion: The approach described in this study harnesses the benefits of nutraceuticals and nanoparticles toward the development of Res-AuNPs. We provide compelling evidence that the increased corona of resveratrol on AuNPs enhances the bioavailability of resveratrol so that therapeutically active species can be optimally available in vivo for applications in cancer therapy.
Keywords: resveratrol, gold nanoparticles, nanotechnology, cancer therapy